Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
Year: 2010
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
DOI: 10.1002/jbmr.173
Institution: Amgen (United States)
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2032956576
